These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 10370190)
1. Microagglomeration of pulverized pharmaceutical powders using the Wurster process I. Preparation of highly drug-incorporated, subsieve-sized core particles for subsequent microencapsulation by film-coating. Ichikawa H; Fukumori Y Int J Pharm; 1999 Apr; 180(2):195-210. PubMed ID: 10370190 [TBL] [Abstract][Full Text] [Related]
2. Use of ion-exchange resins to prepare 100 microm-sized microcapsules with prolonged drug-release by the Wurster process. Ichikawa H; Fujioka K; Adeyeye MC; Fukumori Y Int J Pharm; 2001 Mar; 216(1-2):67-76. PubMed ID: 11274808 [TBL] [Abstract][Full Text] [Related]
3. Improving flow properties of ibuprofen by fluidized bed particle thin-coating. Ehlers H; Räikkönen H; Antikainen O; Heinämäki J; Yliruusi J Int J Pharm; 2009 Feb; 368(1-2):165-70. PubMed ID: 19010403 [TBL] [Abstract][Full Text] [Related]
4. Sustained release coating of tablets with Eudragit(®) RS/RL using a novel electrostatic dry powder coating process. Qiao M; Luo Y; Zhang L; Ma Y; Stephenson TS; Zhu J Int J Pharm; 2010 Oct; 399(1-2):37-43. PubMed ID: 20678560 [TBL] [Abstract][Full Text] [Related]
5. Design and preparation of nanocomposite acrylate coating agents for binder-free dry coating of 100 µm-sized drug-containing particles and their coating performance. Yasunaga T; Andoh T; Ogawa N; Yamamoto H; Ichikawa H Eur J Pharm Biopharm; 2022 Jan; 170():133-143. PubMed ID: 34864196 [TBL] [Abstract][Full Text] [Related]
6. Dry powder coating of pellets with micronized Eudragit RS for extended drug release. Pearnchob N; Bodmeier R Pharm Res; 2003 Dec; 20(12):1970-6. PubMed ID: 14725361 [TBL] [Abstract][Full Text] [Related]
7. Preparation of dry powder inhalation with lactose carrier particles surface-coated using a Wurster fluidized bed. Iida K; Todo H; Okamoto H; Danjo K; Leuenberger H Chem Pharm Bull (Tokyo); 2005 Apr; 53(4):431-4. PubMed ID: 15802846 [TBL] [Abstract][Full Text] [Related]
8. Mechanical particle coating using ethylcellulose nanoparticle agglomerates for preparing controlled release fine particles; effect of coating temperature on coating performance. Kondo K; Ando C; Niwa T Int J Pharm; 2019 Jan; 554():387-398. PubMed ID: 30513400 [TBL] [Abstract][Full Text] [Related]
9. [Development of Solventless Pharmaceutical Technique for Manufacture of Pharmaceuticals]. Kondo K Yakugaku Zasshi; 2024; 144(10):919-930. PubMed ID: 39358247 [TBL] [Abstract][Full Text] [Related]
10. Preparation of core particles for aqueous film coating using agitation fluidized bed. Watano S; Ando K; Miyanami K; Ii Y; Sasatani S Chem Pharm Bull (Tokyo); 1997 Dec; 45(12):2039-42. PubMed ID: 9433775 [TBL] [Abstract][Full Text] [Related]
11. Preparation and characteristics of microcapsules containing enoxacin by one continuous process of agglomeration and microencapsulation. Ueda M; Nakamura Y; Makita H; Kawashima Y J Microencapsul; 1993; 10(2):171-80. PubMed ID: 8331491 [TBL] [Abstract][Full Text] [Related]
12. Spray-coating for biopharmaceutical powder formulations: beyond the conventional scale and its application. Maa YF; Ameri M; Rigney R; Payne LG; Chen D Pharm Res; 2004 Mar; 21(3):515-23. PubMed ID: 15070104 [TBL] [Abstract][Full Text] [Related]
13. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55. Sauer D; Zheng W; Coots LB; McGinity JW Eur J Pharm Biopharm; 2007 Sep; 67(2):464-75. PubMed ID: 17451929 [TBL] [Abstract][Full Text] [Related]
14. Computer simulation of agglomeration in the Wurster process. Fukumori Y; Ichikawa H; Jono K; Takeuchi Y; Fukuda T Chem Pharm Bull (Tokyo); 1992 Aug; 40(8):2159-63. PubMed ID: 1423773 [TBL] [Abstract][Full Text] [Related]
15. Granulation of core particles suitable for film coating by agitation fluidized bed I. Optimum formulation for core particles and development of a novel friability test method. Hamashita T; Nakagawa Y; Aketo T; Watano S Chem Pharm Bull (Tokyo); 2007 Aug; 55(8):1169-74. PubMed ID: 17666839 [TBL] [Abstract][Full Text] [Related]
16. Binder-free dry particulate coating process using a mild vibration field: Effects of glass-transition temperature and powdering method of polymeric coating agents on coating performance. Yasunaga T; Nakamura K; Andoh T; Ichikawa H Int J Pharm; 2019 Apr; 561():206-218. PubMed ID: 30822506 [TBL] [Abstract][Full Text] [Related]
17. Suppression of agglomeration in fluidized bed coating. IV. Effects of sodium citrate concentration on the suppression of particle agglomeration and the physical properties of HPMC film. Nakano T; Yuasa H Int J Pharm; 2001 Mar; 215(1-2):3-12. PubMed ID: 11250087 [TBL] [Abstract][Full Text] [Related]
18. Preparation of microcapsules masking the bitter taste of enoxacin by using one continuous process technique of agglomeration and microencapsulation. Ueda M; Nakamura Y; Makita H; Kawashima Y J Microencapsul; 1993; 10(4):461-73. PubMed ID: 8263675 [TBL] [Abstract][Full Text] [Related]
19. Aqueous coating dispersion (pseudolatex) of zein improves formulation of sustained-release tablets containing very water-soluble drug. Li XN; Guo HX; Heinamaki J J Colloid Interface Sci; 2010 May; 345(1):46-53. PubMed ID: 20129615 [TBL] [Abstract][Full Text] [Related]
20. Characterization of the film formation of the dry coating process. Kablitz CD; Urbanetz NA Eur J Pharm Biopharm; 2007 Sep; 67(2):449-57. PubMed ID: 17451928 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]